Alumis, Inc. (ALMS)

20.01 +1.02 (+5.37%) USD  |  NASDAQ  |  Jun 09, 16:00
19.85 -0.16 (-0.80%) Pre-Market: 08:35
More

Alumis Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for ALMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Nektar Therapeutics Upgrade
Bristol Myers Squibb Co. Upgrade
Amylyx Pharmaceuticals, Inc. Upgrade
Aardvark Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade